Related Experiment Video
Updated: May 14, 2026

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model
Published on: August 16, 2019
Paving the road for CARs in pediatric autoimmune diseases
Mohamad Hamieh1, Virginia Pascual2
1Weill Cornell Medicine, Department of Pediatrics, Meyer Cancer Center, Drukier Institute for Children's Health, Parker Institute for Cancer Immunotherapy, New York, NY, USA.
Abstract:
Severe pediatric autoimmune diseases (AD) have limited therapeutic options. In a recent issue of Nature Medicine, Becilli et al.1 report a case series where CD19 CAR T cell treatment of pediatric AD patients induced rapid and durable remissions with manageable toxicity. Notably, patients discontinued standard therapies, and benefits persisted even after B cell reconstitution, highlighting the potential of a reset of the immune system that warrants further exploration.
More Related Videos
05:22Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor (CAR) T Cell Infusions in Mice
Published on: February 24, 2023
10:15Conditional Reprogramming of Pediatric Human Esophageal Epithelial Cells for Use in Tissue Engineering and Disease Investigation
Published on: March 22, 2017
Related Concept Videos
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune system...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Distribution